WAO Guideline for the Management of Hereditary Angioedema

Brozek, 2009, Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions, Allergy, 64, 669, 10.1111/j.1398-9995.2009.01973.x

Cicardi, 2012, Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group, Allergy, 67, 147, 10.1111/j.1398-9995.2011.02751.x

Munch, 1985, Non-hereditary angioedema treated with tranexamic acid. A 6-month placebo controlled trial with follow-up 4 years later, Allergy, 40, 92, 10.1111/j.1398-9995.1985.tb02666.x

Lewis, 1991, Idiopathic gastric acid hypersecretion: treatment implications for refractory acid/peptic disorders, Aliment Pharmacol Ther, 5, 15

Gluszko, 1994, Administration of gamma interferon in human subjects decreases plasminogen activation and fibrinolysis without influencing C1 inhibitor, J Lab Clin Med, 123, 232

Cicardi, 1995, Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate, Transfusion, 35, 209, 10.1046/j.1537-2995.1995.35395184276.x

Waytes, 1996, Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate, N Engl J Med, 334, 1630, 10.1056/NEJM199606203342503

Cicardi, 1997, Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients, J Allergy Clin Immunol, 99, 194, 10.1016/S0091-6749(97)70095-2

Goring, 1998, Hereditary angioedema in the German-speaking region [in German], Hautarzt, 49, 114

Kunschak, 1998, A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema, Transfusion, 38, 540, 10.1046/j.1537-2995.1998.38698326333.x

Farkas, 1999, The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures, J Oral Maxillofac Surg, 57, 404, 10.1016/S0278-2391(99)90280-X

Bork, 2001, Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema, Arch Intern Med, 161, 714, 10.1001/archinte.161.5.714

Gompels, 2002, A multicentre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency, J Clin Pathol, 55, 145, 10.1136/jcp.55.2.145

Weiler, 2002, Does heparin prophylaxis prevent exacerbations of hereditary angioedema?, J Allergy Clin Immunol, 109, 995, 10.1067/mai.2002.124892

Szeplaki, 2005, Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema, J Allergy Clin Immunol, 115, 864, 10.1016/j.jaci.2004.12.1130

van Doorn, 2005, A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema, J Allergy Clin Immunol, 116, 876, 10.1016/j.jaci.2005.05.019

Bas, 2006, Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant, Allergy, 61, 1490, 10.1111/j.1398-9995.2006.01197.x

Bork, 2007, Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant), J Allergy Clin Immunol, 119, 1497, 10.1016/j.jaci.2007.02.012

Ott, 2007, Treatment of hereditary angioneurotic oedema (HANE) with tibolone, Clin Endocrinol (Oxf), 66, 180, 10.1111/j.1365-2265.2006.02704.x

Schneider, 2007, Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor, J Allergy Clin Immunol, 120, 416, 10.1016/j.jaci.2007.04.028

Varga, 2007, Anti-cholesterol antibody levels in hereditary angioedema, J Cell Mol Med, 11, 1377, 10.1111/j.1582-4934.2007.00124.x

Visy, 2007, Helicobacter pylori infection as a triggering factor of attacks in patients with hereditary angioedema, Helicobacter, 12, 251, 10.1111/j.1523-5378.2007.00501.x

Birjmohun, 2008, Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema, Clin Ther, 30, 2314, 10.1016/j.clinthera.2008.12.021

Cedzynski, 2008, Possible disease-modifying factors: the mannan-binding lectin pathway and infections in hereditary angioedema of children and adults, Arch Immunol Ther Exp (Warsz), 56, 69, 10.1007/s00005-008-0004-7

Szegedi, 2008, Long-term danazol prophylaxis does not lead to increased carotid intima-media thickness in hereditary angioedema patients, Atherosclerosis, 198, 184, 10.1016/j.atherosclerosis.2007.09.025

Craig, 2009, Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks, J Allergy Clin Immunol, 124, 801, 10.1016/j.jaci.2009.07.017

Kreuz, 2009, C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis, Transfusion, 49, 1987, 10.1111/j.1537-2995.2009.02230.x

Bas, 2010, Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series, Ann Emerg Med, 56, 278, 10.1016/j.annemergmed.2010.03.032

Bernstein, 2010, Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks, Ann Allergy Asthma Immunol, 105, 149, 10.1016/j.anai.2010.06.005

Cicardi, 2010, Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema, N Engl J Med, 363, 532, 10.1056/NEJMoa0906393

Cicardi, 2010, Ecallantide for the treatment of acute attacks in hereditary angioedema, N Engl J Med, 363, 523, 10.1056/NEJMoa0905079

Craig, 2010, Prospective study of rapid relief provided by C1 esterase inhibitor in emergency treatment of acute laryngeal attacks in hereditary angioedema, J Clin Immunol, 30, 823, 10.1007/s10875-010-9442-1

Levy, 2010, EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema, Ann Allergy Asthma Immunol, 104, 523, 10.1016/j.anai.2010.04.012

Zuraw, 2010, Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema, J Allergy Clin Immunol, 126, 821, 10.1016/j.jaci.2010.07.021

Zuraw, 2010, Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema, N Engl J Med, 363, 513, 10.1056/NEJMoa0805538

Bissler, 1994, Contiguous deletion and duplication mutations resulting in type 1 hereditary angioneurotic edema, Hum Genet, 93, 265, 10.1007/BF00212020

Zhang, 2000, AluY insertion (IVS4-52ins316alu) in the glycerol kinase gene from an individual with benign glycerol kinase deficiency, Hum Mutat, 15, 316, 10.1002/(SICI)1098-1004(200004)15:4<316::AID-HUMU3>3.0.CO;2-9

Bowen, 2003, Management of hereditary angioedema: a Canadian approach, Transfus Apher Sci, 29, 205, 10.1016/j.transci.2003.08.009

Bowen, 2004, Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema, J Allergy Clin Immunol, 114, 629, 10.1016/j.jaci.2004.06.043

Bracho, 2005, Hereditary angioedema, Curr Opin Hematol, 12, 493, 10.1097/01.moo.0000179805.57486.4e

Chinen, 2005, Basic and clinical immunology, J Allergy Clin Immunol, 116, 411, 10.1016/j.jaci.2005.05.010

Gompels, 2005, C1 inhibitor deficiency: consensus document, Clin Exp Immunol, 139, 379, 10.1111/j.1365-2249.2005.02726.x

Bowen, 2008, Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema, Ann Allergy Asthma Immunol, 100, S30, 10.1016/S1081-1206(10)60584-4

Bowen, 2010, Hereditary angioedema consensus 2010, Allergy Asthma Clin Immunol, 6, 13, 10.1186/1710-1492-6-13

Bowen, 2010, Management of hereditary angioedema: 2010 Canadian approach, Allergy Asthma Clin Immunol, 6, 20, 10.1186/1710-1492-6-20

Bowen, 2010, 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema, Allergy Asthma Clin Immunol, 6, 24, 10.1186/1710-1492-6-24

Longhurst, 2010, HAE international home therapy consensus document, Allergy Asthma Clin Immunol, 6, 22, 10.1186/1710-1492-6-22

Dinkelacker E. Ueber acutes Oedem [dissertation]. Kiel, Germany: Unversity of Kiel; 1882.

Rosen, 1969, The "neurotic edema" (hereditary angioedema), N Engl J Med, 280, 1356, 10.1056/NEJM196906122802414

Cicardi, 1982, Hereditary angioedema: an appraisal of 104 cases, Am J Med Sci, 284, 2, 10.1097/00000441-198207000-00001

Bork, 2006, Hereditary angioedema: new findings concerning symptoms, affected organs, and course, Am J Med, 119, 267, 10.1016/j.amjmed.2005.09.064

Longhurst, 2006, Hereditary angioedema: causes, manifestations and treatment, Br J Hosp Med (Lond), 67, 654, 10.12968/hmed.2006.67.12.22439

Kaplan, 2005, Angioedema, J Am Acad Dermatol, 53, 373, 10.1016/j.jaad.2004.09.032

Seidman, 1990, Angioedema related to angiotensin-converting enzyme inhibitors, Otolaryngol Head Neck Surg, 102, 727, 10.1177/019459989010200617

Nussberger, 1998, Plasma bradykinin in angio-oedema, Lancet, 351, 1693, 10.1016/S0140-6736(97)09137-X

Agostoni, 1999, Angioedema due to angiotensin-converting enzyme inhibitors, Immunopharmacology, 44, 21, 10.1016/S0162-3109(99)00107-1

Rosen, 1965, Hereditary angioneurotic edema: two genetic variants, Science, 148, 957, 10.1126/science.148.3672.957

Roche, 2005, Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain, Ann Allergy Asthma Immunol, 94, 498, 10.1016/S1081-1206(10)61121-0

Bygum, 2009, Hereditary angio-oedema in Denmark: a nationwide survey, Br J Dermatol, 161, 1153, 10.1111/j.1365-2133.2009.09366.x

Donaldson, 1964, Action of complement in hereditary angioneurotic edema: the role of C'1-esterase, J Clin Invest, 43, 2204, 10.1172/JCI105094

Donaldson, 1983, Kinin generation in hereditary angioneurotic edema (H.A.N.E.) plasma, Adv Exp Med Biol, 156, 183

Kaplan, 2002, Pathways for bradykinin formation and inflammatory disease, J Allergy Clin Immunol, 109, 195, 10.1067/mai.2002.121316

Donaldson, 1973, Kinin formation in hereditary angioneurotic edema (HANE) plasma, Int Arch Allergy Appl Immunol, 45, 206, 10.1159/000231029

Fields, 1983, Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin, J Allergy Clin Immunol, 72, 54, 10.1016/0091-6749(83)90052-0

Maurer, 2011, New topics in bradykinin research, Allergy, 66, 1397, 10.1111/j.1398-9995.2011.02686.x

Binkley, 2000, Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema, J Allergy Clin Immunol, 106, 546, 10.1067/mai.2000.108106

Bork, 2000, Hereditary angioedema with normal C1-inhibitor activity in women, Lancet, 356, 213, 10.1016/S0140-6736(00)02483-1

Bork, 2006, Hereditary angio-oedema with normal C1 inhibitor in a family with affected women and men, Br J Dermatol, 154, 542, 10.1111/j.1365-2133.2005.07048.x

Caballero, 2011, Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis, J Investig Allergol Clin Immunol, 21, 333

Karim, 2004, Normal complement C4 values do not exclude hereditary angioedema, J Clin Pathol, 57, 213, 10.1136/jcp.2003.12021

Tarzi, 2007, An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio-oedema, Clin Exp Immunol, 149, 513, 10.1111/j.1365-2249.2007.03438.x

Wagenaar-Bos, 2008, Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations, J Immunol Methods, 338, 14, 10.1016/j.jim.2008.06.004

Zuraw, 2003, Diagnosis and management of hereditary angioedema: an American approach, Transfus Apher Sci, 29, 239, 10.1016/j.transci.2003.08.008

Bork, 2006, Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations, Immunol Allergy Clin North Am, 26, 709, 10.1016/j.iac.2006.09.003

Weiler, 2006, Genetic test indications and interpretations in patients with hereditary angioedema, Mayo Clin Proc, 81, 958, 10.4065/81.7.958

Caballero, 2011, Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situations, J Investig Allergol Clin Immunol, 21, 422

Temino, 2008, The spectrum and treatment of angioedema, Am J Med, 121, 282, 10.1016/j.amjmed.2007.09.024

Zuberbier, 2009, EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria, Allergy, 64, 1427, 10.1111/j.1398-9995.2009.02178.x

Bork, 2009, Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy, J Allergy Clin Immunol, 124, 129, 10.1016/j.jaci.2009.03.038

Farkas, 2001, Angiooedema due to acquired deficiency of C1-esterase inhibitor associated with leucocytoclastic vasculitis, Acta Derm Venereol, 81, 298, 10.1080/00015550152572985

Kaplan, 2001, C1 inhibitor deficiency: hereditary and acquired forms, J Investig Allergol Clin Immunol, 11, 211

Cugno, 2008, Angioedema due to acquired C1inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation, Autoimmun Rev, 8, 156, 10.1016/j.autrev.2008.05.003

Levi, 2006, Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency, J Allergy Clin Immunol, 117, 904, 10.1016/j.jaci.2006.01.002

Bygum, 2009, Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits, Eur J Dermatol, 19, 147, 10.1684/ejd.2008.0603

Gras, 2009, Icatibant for hereditary angioedema, Drugs Today (Barc), 45, 855, 10.1358/dot.2009.45.12.1424267

Bork, 2010, Recurrent angioedema and the threat of asphyxiation, Dtsch Arztebl Int, 107, 408

Martinez-Saguer, 2010, Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate, Am J Obstet Gynecol, 203, 131, 10.1016/j.ajog.2010.03.003

Groner, 2012, Pathogen safety of human C1 esterase inhibitor concentrate, Transfusion, 52, 2104, 10.1111/j.1537-2995.2012.03590.x

Ärzteschaft, 2000, Schwerwiegende Thrombenbildung nach Berinert® HS, Deutsches Ärzteblatt, 97, A

Bork, 2009, Hereditary angioedema: increased number of attacks after frequent treatments with C1 inhibitor concentrate, Am J Med, 122, 780, 10.1016/j.amjmed.2009.02.024

Bork, 2011, Hereditary angioedema: long-term treatment with one or more injections of C1 inhibitor concentrate per week, Int Arch Allergy Immunol, 154, 81, 10.1159/000319213

Varga, 2008, Treatment of type I and II hereditary angioedema with Rhucin, a recombinant human C1 inhibitor, Expert Rev Clin Immunol, 4, 653, 10.1586/1744666X.4.6.653

Sheffer, 2011, Ecallantide (DX-88) for acute hereditary angioedema attacks: integrated analysis of 2 double-blind, phase 3 studies, J Allergy Clin Immunol, 128, 153, 10.1016/j.jaci.2011.03.006

Bygum, 2011, Rapid resolution of erythema marginatum after icatibant in acquired angioedema, Acta Derm Venereol, 91, 185, 10.2340/00015555-1055

Bork, 2011, Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 112, 58, 10.1016/j.tripleo.2011.02.034

Zuraw, 2008, Hereditary angiodema: a current state-of-the-art review, IV: short-and long-term treatment of hereditary angioedema: out with the old and in with the new?, Ann Allergy Asthma Immunol, 100, S13, 10.1016/S1081-1206(10)60581-9

Maurer, 2010, Hereditary angioedema: an update on available therapeutic options, J Dtsch Dermatol Ges, 8, 663

Van Sickels, 2010, Hereditary angioedema: treatment, management, and precautions in patients presenting for dental care, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 109, 168, 10.1016/j.tripleo.2009.09.031

Gompels, 2011, Cinryze (C1-inhibitor) for the treatment of hereditary angioedema, Expert Rev Clin Immunol, 7, 569, 10.1586/eci.11.50

Lunn, 2010, Cinryze as the first approved C1 inhibitor in the USA for the treatment of hereditary angioedema: approval, efficacy and safety, J Blood Med, 1, 163, 10.2147/JBM.S9576

Tallroth, 2011, Long-term prophylaxis of hereditary angioedema with a pasteurized C1 inhibitor concentrate, Int Arch Allergy Immunol, 154, 356, 10.1159/000321830

Blackmore, 1977, Danazol in the treatment of hereditary angio-neurotic oedema, J Int Med Res, 5, 38

Agostoni, 1980, Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema, J Allergy Clin Immunol, 65, 75, 10.1016/0091-6749(80)90181-5

Wharton, 1982, Hereditary angioedema: response to danazol, Practitioner, 226, 935

Zurlo, 1990, The long-term safety of danazol in women with hereditary angioedema, Fertil Steril, 54, 64, 10.1016/S0015-0282(16)53638-3

Cicardi, 1991, Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience, J Allergy Clin Immunol, 87, 768, 10.1016/0091-6749(91)90120-D

Bork, 2002, Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema, J Hepatol, 36, 707, 10.1016/S0168-8278(02)00035-1

Bork, 2008, Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients, Ann Allergy Asthma Immunol, 100, 153, 10.1016/S1081-1206(10)60424-3

Farkas, 2010, The effect of long-term danazol prophylaxis on liver function in hereditary angioedemada longitudinal study, Eur J Clin Pharmacol, 66, 419, 10.1007/s00228-009-0771-z

Maurer, 2011, Long-term prophylaxis of hereditary angioedema with androgen derivates: a critical appraisal and potential alternatives, J Dtsch Dermatol Ges, 9, 99

Sheffer, 1972, Tranexamic acid therapy in hereditary angioneurotic edema, N Engl J Med, 287, 452, 10.1056/NEJM197208312870907

Crosher, 1987, Intravenous tranexamic acid in the management of hereditary angio-oedema, Br J Oral Maxillofac Surg, 25, 500, 10.1016/0266-4356(87)90143-4

Farkas, 2002, Clinical management of hereditary angio-oedema in children, Pediatr Allergy Immunol, 13, 153, 10.1034/j.1399-3038.2002.01014.x

Caballero, 2012, International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency, J Allergy Clin Immunol, 129, 308, 10.1016/j.jaci.2011.11.025

Boyle, 2005, Hereditary angio-oedema in children: a management guideline, Pediatr Allergy Immunol, 16, 288, 10.1111/j.1399-3038.2005.00275.x

Farkas, 2010, Pediatric hereditary angioedema due to C1-inhibitor deficiency, Allergy Asthma Clin Immunol, 6, 18, 10.1186/1710-1492-6-18

Martinez-Saguer, 2010, Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study, Transfusion, 50, 354, 10.1111/j.1537-2995.2009.02394.x

Caballero T. Angio-oedema due to hereditary C1 inhibitor deficiency in children. Allergol Immunopathol (Madr). 2012.

Kjaer L, Bygum A. Hereditary angioedema in childhood: a challenging diagnosis you cannot afford to miss. Pediatr Dermatol. 2012.

Davis, 1979, Serum complement levels in infancy: age related changes, Pediatr Res, 13, 1043, 10.1203/00006450-197909000-00019

Roach, 1981, Influence of age and sex on serum complement components in children, Am J Dis Child, 135, 918

Nielsen, 1994, C1 inhibitor and diagnosis of hereditary angioedema in newborns, Pediatr Res, 35, 184, 10.1203/00006450-199402000-00012

Wahn, 2012, Hereditary angioedema (HAE) in children and adolescents--a consensus on therapeutic strategies, Eur J Pediatr, 171, 1339, 10.1007/s00431-012-1726-4

Yip, 1992, Hormonally exacerbated hereditary angioedema, Australas J Dermatol, 33, 35, 10.1111/j.1440-0960.1992.tb00050.x

Visy, 2004, Sex hormones in hereditary angioneurotic oedema, Clin Endocrinol (Oxf), 60, 508, 10.1111/j.1365-2265.2004.02009.x

Bouillet, 2008, Disease expression in women with hereditary angioedema, Am J Obstet Gynecol, 199, 484, 10.1016/j.ajog.2008.04.034

Cox, 1995, Hereditary angioneurotic oedema: current management in pregnancy, Anaesthesia, 50, 547, 10.1111/j.1365-2044.1995.tb06050.x

Duvvur, 2007, Hereditary angioedema and pregnancy, J Matern Fetal Neonatal Med, 20, 563, 10.1080/14767050701411851

Bouillet, 2010, Hereditary angioedema in women, Allergy Asthma Clin Immunol, 6, 17, 10.1186/1710-1492-6-17

Czaller, 2010, The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey, Eur J Obstet Gynecol Reprod Biol, 152, 44, 10.1016/j.ejogrb.2010.05.008

Montinaro, 2010, Management of pregnancy and vaginal delivery by C1 inhibitor concentrate in two hereditary angioedema twins, Clin Immunol, 136, 456, 10.1016/j.clim.2010.05.008

Longhurst, 2007, C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option, Clin Exp Immunol, 147, 11, 10.1111/j.1365-2249.2006.03256.x

Aygoren-Pursun, 2010, On demand treatment and home therapy of hereditary angioedema in Germany--the Frankfurt experience, Allergy Asthma Clin Immunol, 6, 21, 10.1186/1710-1492-6-21

Farkas, 2012, Home treatment of hereditary angioedema with icatibant administered by health care professionals, J Allergy Clin Immunol, 129, 851, 10.1016/j.jaci.2011.10.039

Kreuz, 2012, Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedema, Transfusion, 52, 100, 10.1111/j.1537-2995.2011.03240.x

Tourangeau, 2012, Safety and efficacy of physician-supervised self-managed c1 inhibitor replacement therapy, Int Arch Allergy Immunol, 157, 417, 10.1159/000329635

Wilson, 2010, Economic costs associated with acute attacks and long-term management of hereditary angioedema, Ann Allergy Asthma Immunol, 104, 314, 10.1016/j.anai.2010.01.024

Zilberberg, 2010, The burden of hospitalizations and emergency department visits with hereditary angioedema and angioedema in the United States, 2007, Allergy Asthma Proc, 31, 511, 10.2500/aap.2010.31.3403

Gorman, 2008, Hereditary angioedema and pregnancy: a successful outcome using C1 esterase inhibitor concentrate, Can Fam Physician, 54, 365

Farkas, 2001, Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema, Lancet, 358, 1695, 10.1016/S0140-6736(01)06720-4

Bork, 2003, Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema, J Am Dent Assoc, 134, 1088, 10.14219/jada.archive.2003.0323